Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva Pharma acquires rights to Huntexil for $26M
Teva Pharma acquires rights to Huntexil for $26M
Teva Pharma acquires rights to Huntexil for $26M
Submitted by
admin
on September 28, 2012 - 10:35am
Source:
Yahoo/AP
News Tags:
Teva Pharmaceuticals
Huntexil
Huntington's disease
Neurosearch
Headline:
Teva Pharma acquires rights to Huntexil for $26M
Do Not Allow Advertisers to Use My Personal information
